论文部分内容阅读
据京都新闻7月1日报道:白血病来源于幼稚的白细胞(白血病细胞),现已发现能分化诱导幼稚白细胞并使之成熟的物质。6月30日在京都召开的“动物细胞培养工程学国际讨论会”上,美国罗兹维尔帕克癌研究所的蓑和田润博士发表了这一发现,认为应用这种物质可能治疗白血病。白血病分为淋巴细胞性和粒细胞性两种。粒细胞性白血病有人称为造血组织的原发性肿瘤性疾病,血液中未分化的病理的幼稚白细胞是发病的原因。蓑和田博士取出人的不同种类的T细胞进行组织培养,同时加入白血病细胞,发现白血病细胞在T细胞中分
According to the Kyoto News on July 1 reported: leukemia derived from naive leukocytes (leukemia cells), has been found to differentiate and induce naive leukocytes and mature substances. On June 30 at the “International Symposium on Animal Cell Culture Engineering” in Kyoto, Dr. Haruhito, a researcher at the Parks Cancer Institute in Roswell, USA, published this discovery and concluded that the use of this substance may lead to the treatment of leukemia. Leukemia is divided into two kinds of lymphocytic and granulocytic. Granulocytic leukemia is called a primary tumor of hematopoietic tissue disease, immature leukocytes in the undifferentiated pathology of the blood is the cause.蓑 Dr. He Wada removed different types of human T cells for tissue culture, while adding leukemia cells found in leukemia cells in T cells